Athletes can feel the relief a substance gives them long before they can see what it costs. A composite case of cannabis use in a track athlete shows how to assess both.
News|Articles|May 28, 2024
Psychedelics Recent Research Poll
Author(s)Psychiatric Times Editors
Answer a quick question on psychedelics!
Advertisement
To what extent are you familiar with recent research findings on the therapeutic potential of psychedelics in psychiatric treatment?
Advertisement
Related to this article
Phase 3 psilocybin and LSD data plus new FDA guidance fuel a depression boom—yet clinics still wrestle with dosing time, cost, access.
Nearly half of US adults who drink and use cannabis combine them at once; cannabis use disorder drives the trend, signaling urgent screening needs.
Advertisement
Advertisement
Trending on Psychiatric Times
1
What Makes Us Human? The Role of Psychiatry and the Future DSM
2
The First Ever Treatment-Resistant Depression Awareness Day
3
Relief Is Not Free: A Case Study of Athlete Cannabis Use
4
How Best to Manage Treatment-Resistant Depression
5